Indivior Pharmaceuticals files Form 425
Indivior Pharmaceuticals filed a Form 425 on October 29.
Related stories
CorMedix Shares Hit 52-Week Low After DaVita Flags 2027 Reimbursement Drop
CorMedix shares fell nearly 26% on Friday, hitting a fresh 52-week low after DaVita warned that Medicare reimbursement for DefenCath could drop sharply in 2027.
M impact | EQUITY | Oct 30, 2026, 07:51 PM UTC
Broadcom Shares Fall 5.24% to $326.91
Broadcom shares fell 5.24% to $326.91 at 11:25 a.m. ET on October 30.
M impact | EQUITY | Oct 30, 2026, 07:41 PM UTC
SK Hynix Shares Fall 7.08% on October 30
SK Hynix shares closed down 7.08% on October 30. The company outlined a shareholder payout alongside its earnings announcement.
M impact | EQUITY | Oct 30, 2026, 07:41 PM UTC
Amazon Arranges Up to $80 Billion Supplier Financing Credit Line
Amazon arranged a supplier financing credit line of up to $80 billion as it prepares for infrastructure spending on AI initiatives.
H impact | EQUITY | Oct 30, 2026, 07:37 PM UTC
Twilio Shares Fall 17.26% Despite Nearly 24% Free-Cash-Flow Margin
Twilio fell 17.25% to $200.16 on October 30. Its growth outlook overshadowed strong cash generation, the report says.
M impact | EQUITY | Oct 30, 2026, 07:32 PM UTC
AMD Shares Fell Nearly 10% Friday as Chip Demand Concerns Grew
AMD shares dropped nearly 10% in Friday morning trading as investors questioned whether chip-industry demand could hold up after a rival’s disappointing outlook. AMD is scheduled t
M impact | EQUITY | Oct 30, 2026, 07:31 PM UTC